Jessie J Cancer Free in 2026: What Early-Stage Breast Cancer and a One-Year MRI Mean

Jessie J announced she is cancer free in May 2026 after early-stage breast cancer and mastectomy in 2025.

Jessie J posted on Instagram this May 21 to share she was cleared for a one-year post-treatment MRI and declared she is cancer free. Diagnosed with stage one breast cancer at age 37 in March 2025, Jessie J underwent a mastectomy followed by reconstruction surgery in summer 2025. In the UK, more than 95 to 98 percent of women diagnosed with stage one breast cancer survive for five years or more. The normal process on the UK NHS pathway takes from referral from the GP under the two-week wait through triple assessment at a breast clinic to surgery, adjuvant treatments and an annual scan.

Late Monday night, 21 May, Jessie J posted a video on her Instagram feed. She filmed the footage while in a hospital gown and waiting to have her one-year follow-up MRI scan. In the clip, she described having spent hours crying with disappointment at the hospital following her diagnosis. But Monday she was finally able to sigh and inhale fully after one year without incident, she was told that all the results from the scans had come back clear and Jessie J is cancer free. She first started noticing issues back at the end of March when, age 37, she was diagnosed with early-stage breast cancer. She then had surgery for a single mastectomy and breast reconstruction in summer 2025 and has described some of the struggles that came with her recovery. She hopes sharing her story will serve to tell others the practical facts for what this really means for people here in the United Kingdom.

What early-stage breast cancer means in plain terms

Early breast cancer is generally referred to as stage 0, stage I or stage IIA breast cancer. It is crucial to understand the staging system, as it can predict a patient’s outlook and help medical professionals recommend treatments that are appropriate for their individual condition. Stage 0 breast cancer can refer to a condition called ductal carcinoma in situ (DCIS), where the cancer cells have stayed in the milk ducts. It does not typically involve other tissues in the breast. In stage I breast cancer, the cancer has started to become invasive, usually being a small tumor under two centimeters that has not spread to any nearby lymph nodes. With Stage IIA, the tumor may be larger, but the cancer has not yet spread to nearby lymph nodes. If the tumor is smaller than stage I (less than two centimeters), then stage IIA would involve some spread to nearby lymph nodes (three or fewer).

If diagnosed at stage 0, I or IIA, your survival rates are considered high. Survival rates for cancer patients in the U.K. are high for those with stage I and IIA disease: around 98 percent in five years. Only five percent of all diagnoses occur in women under the age of 40, which is fairly uncommon. However, the tumor may be more biologically aggressive in younger women. A more intensive diagnostic evaluation with multiple treatments often occurs, along with gene expression testing of tumors and DNA testing for genetic mutations. With every diagnosis, understanding the status of one’s breast cancer receptors can inform appropriate treatment. Receptor status indicates whether your cancer cells have proteins that respond to hormones like estrogen or progesterone, or to growth signals called HER2 receptors. This largely helps the medical team to identify which types of treatments (e.g., hormone therapy or targeted therapies) might be beneficial after surgery.

Early-stage diagnosis implies a much stronger survival outlook with standard treatment methods. In addition to size, lymph node involvement and tumor invasiveness, a crucial aspect in understanding any type of breast cancer is the receptor status of the cancer cells.

The UK NHS pathway from new lump to diagnosis

If you discover any new breast lump, breast skin change or persistent change to your nipple, see your GP and book an appointment to get it examined. They will then decide if referral to a breast clinic under the two-week suspected cancer wait route is needed. Two-week wait referrals are used for such things as a discrete breast lump in women over 30, suspicious skin dimpling, a new lump in women over 50, changes to the nipple area like inversion or bloody discharge and areas of abnormal scaling of the skin on the breast.

At a breast clinic you will have triple assessment – examination, imaging and a biopsy. For women aged 40 or over, imaging is most commonly a mammogram, sometimes accompanied by an ultrasound. For women younger than 35-40, the first type of scan is typically an ultrasound. If the ultrasound or mammogram highlights any abnormal areas, the specialist might offer an ultrasound-guided core needle biopsy to get cells for lab analysis.

The biopsy results are usually returned within five to ten working days. Just so you know, about 9 in 10 women seen on the two-week wait pathway are found not to have cancer – it is benign symptoms which are causing these changes in most referrals. If the results show cancer is present, your case is put forward for a multidisciplinary team meeting. You will then have a consultation with a breast care team who will go through your test results and treatment plan in detail. Although Jessie J had private healthcare, the route to diagnosis, the clinical steps taken and evidence used are similar to the process you would go through with NHS care.

Mastectomy and breast reconstruction in 2026

A mastectomy is an operation to surgically remove all of the breast tissue. The different types of mastectomy vary depending on the position and size of the cancer and the extent of operation needed for oncological safety.

Simple (or total) mastectomy: removes all the breast tissue, as well as the nipple, areola and the nipple-macrophage complex.

Skin-sparing mastectomy: removes the breast tissue and nipple as well as over the cancer itself, but spares much of the breast skin envelope so as to aid the reconstruction.

Nipple-sparing mastectomy: removes all the breast tissue, but leaves the skin and nipple complex intact.

Breast reconstruction

Reconstruction may occur simultaneously (immediate reconstruction) or may follow (delayed reconstruction) the mastectomy. The options include:

Implant reconstruction: uses a silicone gel implant placed either over or under the chest muscle. Occasionally, a tissue expander may be placed initially to stretch the skin over time.

Autologous reconstruction (or TRAM or DIEP flap): uses tissue (usually skin and fat) from another part of the body (most commonly from the lower abdomen using a DIEP flap or less commonly the back with a latissimus dorsi flap).

Advantages and disadvantages

Both types of surgery come with trade-offs. Implant surgery usually takes less time in theatre, recovery time is typically quicker at the immediate post-op stage, but implants are not a lifelong device and a secondary surgery will likely be needed in future. With autologous flaps such as the DIEP flap, the feel and result can last a lifetime, look more natural and do not require revision or replacement at some stage, but the operation takes longer and requires surgery at two different sites, meaning a longer and often more difficult recovery time. Both are funded by the NHS. Recovery after a mastectomy followed by an implant reconstruction takes approximately 4-6 weeks until return to most normal daily activities. The DIEP flap usually takes approximately 6-8 weeks to recover from. In the long term, patients might develop a stiff shoulder or lymphoedema (swelling). Jessie J has spoken about needing patience and dealing with her body image after her cancer surgery, which is a common experience that most women go through in their healing journey.

Adjuvant therapy and the one-year mark

Once surgery is finished, most women undergo some kind of adjuvant treatment. Depending on how your tumor behaves—at what stage it is, how aggressive it looks under the microscope, what its hormone status (ER/PR) and HER2 status are—your doctor will recommend additional therapy. Radiation therapy is generally used for women with breast-conserving surgery. It can also be used for women after a mastectomy if the tumor is of significant size and if the lymph nodes have had cancer spread into them.

Some women are recommended for chemotherapy if they have a higher risk type of cancer. For women with hormone receptor positive breast cancer, an additional genetic test, Oncotype DX or Prosigna, might be performed. These tests can predict the relative benefit of giving chemotherapy to increase overall survival and reduce the chance of recurrence. For women who have hormone receptor positive breast cancer, long-term endocrine treatment is the standard adjuvant therapy, often tamoxifen or an aromatase inhibitor for 5-10 years. If the cancer is HER2 positive, then women are usually recommended to have HER2 targeted treatments like trastuzumab, often administered for a year.

The one-year mark after cancer diagnosis is a special time for two reasons: first, you will have normally finished your intense phase of treatment like surgery, chemotherapy and radiotherapy, which means your body and your mind can start to rest. Second, you will be scanned (MRI in many cases) around 6-12 months post-operation. Once a negative scan has come back, this offers reassurance that the treatments are doing their work and no local recurrence has occurred. It marks the milestone of a first positive result, like the one Jessie J reached, but this is a stepping stone toward many more years of regular screening.

Follow-up imaging, recurrence risk and the all-clear

There is not one particular moment that one could call ‘all clear’ after treatment for early-stage breast cancer. Follow-up care will continue for at least five years. In the UK, the recommended standard follow-up imaging will be an annual mammogram on both the affected breast and the opposite breast alongside a clinical review by the breast team. For those at higher risk (due to BRCA1/2 gene mutations or dense breast tissue), an MRI scan may be added.

Cancer has the highest risk of coming back in the five years following treatment, although for hormone-receptor positive breast cancer, low-risk can continue to persist for at least 20 years. Cancer Research UK indicates 10-year survival for stage I breast cancer stands around 90%, while 10-year survival rates for stage II disease stand at between 80% and 85%. For Jessie J, a clear MRI on her one-year anniversary is brilliant news, but does not signify the end of surveillance. Imaging should continue each year until the breast cancer risk has been minimised.

Understanding receptor status from pathology tests is key to determining the most effective adjuvant therapy after surgery.

Mental health, scanxiety and emotional recovery

Anxiety and depression can persist well after breast cancer treatment. Between a third and 40% of patients have clinically significant anxiety or depression during the year after treatment. You will likely have significant emotional changes to your body relationship, sleeping patterns and your sense of your security around the future.

Scan anxiety—worry in the weeks before each follow-up scan appointment—is real. Jessie J’s video while dressed in her hospital gown awaiting an MRI demonstrates the fear clearly. She went from sobbing for hours after receiving her initial diagnosis to a huge relief at her all-clear. The medical reality is that her clear one-year MRI is a brilliant outcome, as she now enters a phase of continued annual imaging as per standard protocol.

The NHS has plenty of resources. Your GP can give you a referral to NHS Talking Therapies, offering cognitive behavioural therapy (CBT) or counselling. Your breast care nurse specialist is an excellent listener who can offer reassurance or practical advice. Macmillan Cancer Support offers a free national telephone helpline (0808 808 00 00) staffed by cancer nurses. Breast Cancer Now provides the free Someone Like Me service, connecting you with a volunteer who has been through breast cancer. Maggie’s Centres next to cancer hospitals run free drop-in psychological support services. Accepting how you are feeling, keeping up a relatively normal routine, getting plenty of sleep and allowing yourself to grieve your pre-breast cancer body is really helpful.

What to do if you or someone you know finds a breast lump

First, try not to panic. Most breast lumps, especially in women under 35, are not cancer. Common benign causes include cysts and fibroadenomas. However, it is always important to get any new or persistent change checked.

Book a GP appointment promptly. Do not wait several menstrual cycles to see if the lump changes. UK NHS guidance is clear: see your GP for any new breast lump, skin dimpling, nipple retraction or unusual discharge that worries you.

If you are referred to a breast clinic, expect triple assessment. This includes clinical examination, imaging (ultrasound if you are under 35-40, mammogram if over 40) and biopsy if needed. Most clinics are able to do this in a single visit. At your first clinic appointment, ask for the contact details of the breast care nurse. This nurse will be the steady hand throughout your process.

If you can, bring along a trusted friend or family member to your results appointment. It is hard to process information or make decisions alone under stress. If cancer is confirmed, ask for written information and the names of your treatment team. Remember that the NHS two-week wait pathway is built for speed and efficiency. While most people referred this way are not ill, the pathway is there so those who do have cancer can be diagnosed quickly. Be kind to yourself. The initial few weeks of uncertainty are often the toughest part of this entire process.

Frequently Asked Questions

What did Jessie J announce in May 2026?

On Sunday 21 May, the singer uploaded a clip to Instagram while sitting in a hospital gown, awaiting her one-year follow-up MRI scan, which came back clear. She wrote: ‘They got the all-clear this morning. I am now cancer free!’ She had been diagnosed with early-stage breast cancer in March 2025, aged 37, and underwent a mastectomy and reconstruction surgery in summer 2025.

What constitutes an early stage of breast cancer?

Generally speaking, early-stage breast cancer involves stages 0, I or IIA disease. DCIS (stage 0) remains in the milk ducts. Stage I indicates a small invasive tumor that has not yet spread to the lymph nodes. Stage IIA signifies a larger tumor or a small one with some spread to nearby lymph nodes. Based on Cancer Research UK data, 5-year survival rates for early-stage breast cancer range between 95 and 98%.

What is the NHS pathway for a new breast lump?

The process on the NHS begins with a GP visit. If your GP suspects cancer, they will refer you to a breast clinic via the ‘two-week wait’ pathway. At the clinic, you will have a triple assessment: a specialist physical examination, imaging (ultrasound if under 40, mammogram if over 40) and sometimes a needle biopsy. Most lumps are benign, with just under 1 in 10 women on this pathway confirmed as having cancer.

What are the types of mastectomy and reconstruction?

A mastectomy removes all breast tissue. Types include simple mastectomy, skin-sparing mastectomy, and nipple-sparing mastectomy. Reconstructive surgery uses either a silicone implant or autologous (own) tissue flap, such as a DIEP flap from the abdomen. Reconstruction can be immediate or delayed and is funded by the NHS. Recovery takes 4-6 weeks for implants and 6-8 weeks for flap procedures.

What does the one-year mark after breast cancer treatment mean?

The first follow-up scan usually occurs at six to 12 months after treatment. A clear scan at the one-year mark (mammogram or MRI) provides the first major positive news in the follow-up process. However, it does not end surveillance. The NHS standard is an annual mammogram for at least five years. Further MRIs may be added for women with dense breast tissue or a higher genetic risk.

What is scanxiety and how do you cope with it?

Scanxiety is the anxiety felt in the days or weeks before a follow-up cancer scan. It is common at any stage. Coping strategies include acknowledging the feeling, arranging a calm day around the appointment, avoiding caffeine, having a friend for support, planning a nice activity afterwards, and speaking to your GP about a referral to NHS Talking Therapies if anxiety is overwhelming.

Where can you find breast cancer support in the UK?

In the UK, Breast Cancer Now offers a helpline (0808 800 6000) and a ‘Someone Like Me’ peer support service. Macmillan Cancer Support has a free helpline (0808 808 00 00). Maggie’s Centres offer drop-in psychological support near hospitals, and you can self-refer to NHS Talking Therapies online. Your breast care nurse is also a key source of support and information.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.